Company Filing History:
Years Active: 1991-2002
Title: Thomas L Reiland: Innovator in Lipid-Regulating Agents
Introduction
Thomas L Reiland, an inventive mind hailing from Gages Lake, IL, has made significant contributions to pharmaceutical chemistry with a total of six patents to his name. His work focuses primarily on the development of solid formulations for lipid-regulating agents, which are crucial for the treatment of various metabolic conditions.
Latest Patents
Among his latest patents, two stand out prominently:
1. **Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption** - This patent details a unique process involving the dissolution of lipid-regulating agent particles in a surfactant solution, followed by premixing an excipient, wet granulation, drying, and finally forming a finished dosage form.
2. **Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption** - This patent outlines a different approach where a mixture of lipid-regulating agents and a surfactant is formed, followed by granulation through melting, mixing, and congealing, leading to an optional finished dosage form.
Career Highlights
Thomas is currently associated with Abbott Laboratories Corporation, a leading global health care company known for its innovative products in the pharmaceutical industry. Throughout his career, he has leveraged his expertise to develop formulations that improve the therapeutic efficacy of lipid-regulating agents.
Collaborations
Collaboration plays a crucial role in Thomas's work. He has teamed up with notable colleagues such as Kevin R Engh and Yihong Qiu, among others, to push the boundaries of formulation science and enhance the effectiveness of lipid-regulating agents.
Conclusion
In summary, Thomas L Reiland’s innovative approaches in the preparation of solid formulations for lipid-regulating agents reflect his commitment to enhancing patient care through better medication delivery. His contributions, alongside collaborative efforts, continue to make a meaningful impact in the field of pharmaceuticals.